Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16397040 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
Condition: Cancer
Interventions: Drug: NGR-hTNF;   Drug: Doxorubicin

Indicates status has not been verified in more than two years